Bio News
Shanghai Jiao Tong University converted cancer cells into a vaccine that delivers four genes to the cells, enabling them to present their own antigens. These reprogrammed cancer cells activated CD4+ and CD8+ T cells without professional antigen-presenting cells and induced complete tumor remission in mouse models. The findings open the possibility of overcoming treatment resistance through future combination therapy with immune checkpoint inhibitors.
BIOBOOK TEAM
biobookmedia@biobook.co.krParagon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos
Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%
BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial
Roche Signs $1.6 Billion Deal With China’s Rona for ALK7 Obesity Drug
Formycon and Zydus’ Keytruda Biosimilar Is First to Be Accepted for FDA Review
Pfizer Signs $500 Million Protein Degrader Deal With Enodia
